Marshall Wace

Marshall Wace’s Astria Therapeutics ATXS Stock Holding History

Marshall Wace’s Portfolio ATXS Stock Details ATXS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$5.31M	Buy
2024 Q2	–	Sell
2024 Q1	$989K	Buy
2023 Q4	$110K	Buy
2023 Q2	–	Sell
2023 Q1	$412K	Buy
2022 Q4	$223K	Buy